Dr Hyung-Jun Im, MD, Ph.D., is an Associate Professor and Associate Dean at the Graduate School of Convergence Science and Technology, Seoul National University, Republic of Korea. He is also the principal investigator at the Translational Molecular Imaging and Theranostics Lab (http://tmtl.snu.ac.kr/) at Seoul National University.
Dr. Im earned his MD degree from the School of Medicine at The Catholic University of Korea in 2007 and underwent residency and fellowship training in Nuclear Medicine at Seoul National University Hospital. He also earned a Ph.D. degree from the Department of Molecular Medicine and Biopharmaceutical Sciences at Seoul National University in 2015 and completed two years of post-doctoral training in the Department of Radiology at the University of Wisconsin-Madison.
Dr. Im conducts leading research in the fields of nuclear medicine, nanomedicine, and theranostics. He has authored 87 research papers in these fields (H-index = 31), including works in Nature Biomedical Engineering, Journal of Nuclear Medicine, Radiology, ACS Nano and Theranostics. Additionally, he has written 6 chapters in textbooks related to nuclear medicine and nanomedicine, and holds a record of 15 patent applications, 3 patent registrations, and 2 technology transfers.
In terms of professional affiliations and leadership roles outside his university professorship, Dr. Im has been an active member of the Young Korean Academy of Science and Technology (Y-KAST) since 2022. He has also served as Associate Editor for the Journal of Nanobiotechnology since 2021. He has held positions of Planning Director of the Korean Society of Nanomedicine and Assistant Academic Director of the Korean Society of Nuclear Medicine. Furthermore, he is a co-founder and the Chief Scientific Officer of Portrai Inc.
Dr. Im has been the recipient of numerous awards and honors, showcasing his expertise and significant contributions to the field. In 2022, he was honored as a member of the Young Korean Academy of Science and Technology (Y-KAST). A year prior, in 2021, he was spotlighted in the "Ones to Watch" by the Society of Nuclear Medicine and Molecular Imaging. Dr. Im was recognized as a SNU (Seoul National University) Creative-leading young researchers in 2019, a year which also saw him receiving the Asian Young Investigator Award from the Japanese Society of Nuclear Medicine, and The Best Paper Award from the Korean Society of Nuclear Medicine. His excellence in research was also acknowledged at the Korea-U.S. Forum on Nanotechnology with The Best Poster Award, following a similar recognition at the prior forum in 2018. Also, Dr. Im received the Young Investigator Award by the Society of Nuclear Medicine and Molecular Imaging in 2016.